S Amiel
Thu 21 10:30
CMW4.1
Clinical Management Workshop 4: Managing Hypoglycaemia
Hypoglycaemia in diabetes - effects on cerebral and autonomic function
G Anderson
Wed 20 13:45
S12.1
Symposium 12: Thymic function and autoimmune endocrine disease
The thymus medulla, Aire, and autoimmunity
R Andrew
Edinburgh, UK
Wed 20
MTE9
Meet The Expert 9
Biomedical mass spectrometry - moving forward
Edinburgh, UK
W Arlt
Thu 21 09:45
CG1.2
Clinical Guidelines
Adults with CAH
S Aylwin
Wed 20 09:00
N1.1
Nurse Session 1: The Patient Pathway for Pituitary Care
Overview and workup
Dr John Ayuk
Birmingham
Tue 19 08:35
CMW2.2
Clinical Management Workshop 2: How Do I Do It?
How do I investigate and manage hypomagnesaemia?
Birmingham
A Balen
Thu 21 10:30
CMW3.1
Clinical Management Workshop 3: PCOS - why, how and what
Consensus on women's health aspects of PCOS
I Banerjee
Tue 19 09:35
CMW2.5
Clinical Management Workshop 2: How Do I Do It?
How and when do I induce puberty in males?
S Baron-Cohen
Mon 18 16:15
S5.1
Symposium 5: Sex in the brain
Foetal testosterone in mind
P Beck-Peccoz
Milan, Italy
Tue 19 15:00
S7.3
Symposium 7: Thyroid Hormone Receptors - mutations and implications
Human thyroid hormone receptor beta mutations - syndrome of resistance to thyroid hormone
Milan, Italy
G Begum
Tue 19 14:45
OC4.3
Oral Communications 4: Obesity, metabolism and bone
Adult offspring of undernourished sheep exhibit epigenetic alterations in HPA axis glucocorticoid receptor
L Bentley
Mon 18 17:30
OC2.6
Oral Communications 2: Steroids and thyroid
An N-ethyl-N-nitrosourea induced Corticotrophin releasing hormone (Crh) promoter mutation provides a mouse model of Cushing’s syndrome
J Bevan
Tue 19 09:15
CMW2.4
Clinical Management Workshop 2: How Do I Do It?
How do I manage the pregnant patient with a prolactinoma?
Tue 19
Ipsen satellite symposium
High-dose lanreotide Autogel for treatment-naive patients with acromegaly: the PRIMARYS trial
Wed 20 10:30
EW2.5
Education Workshop 2: How to get your research published
Clinical Endocrinology
A Bianco
Miami, USA
Wed 20
PL5
BTA Pitt-Rivers Lecture
Regulation of Tissue-Specific Regulation of Thyroid Hormone Action
Miami, USA
Stephen Bloom
Wed 20 15:15
S11.4
Symposium 11: Guts, brains and bariatric surgery
Gut hormones: a cure for obesity
B Boucher
Thu 21 11:45
SE1.4
Senior Endocrinologists' Session
Vitamin D action on the Renin/Angiotensin system in pancreas and liver
G Brabant
Wed 20 14:25
N2.2
Nurse Session 2: Late Effects
Thyroid late effects
M Brandi
Florence, Italy
Mon 18 16:15
CMW1.1
Clinical Management Workshop 1: Management controversies in parathyroid disease
Hyperparathyroidism in MEN1
Florence, Italy
T Brue
Marseille, France
Tue 19 18:00
S8.4
Symposium 8: Non functioning pituitary tumours
Aggressive pituitary tumours and temozolomide treatment
Marseille, France
J Cegia
Tue 19 15:00
OC4.5
Oral Communications 4: Obesity, metabolism and bone
Energy intake following infusion of glucagon and GLP-1: a double-blind crossover study
T Cheetham
Tue 19 17:45
MTE5
Meet the Expert 5
Challenges in managing hyperthroidism in young people
D Chen
Mon 18 18:00
OC2.8
Oral Communications 2: Steroids and thyroid
When math meets biology: systems approach to drug resistance analysis
S Chen
Tue 19 08:30
OC3.2
Oral Communications 3: Reproduction, growth and development
Heterodimerisation of gonadotrophin hormone receptors modifies the LH-induced calcium signalling profile
S-Y Cheng
Bethesda, USA
Tue 19 15:30
S7.4
Symposium 7: Thyroid Hormone Receptors - mutations and implications
Nuclear coregulators confer the actions of mutant thyroid hormone receptor alpha and beta
Bethesda, USA
J Christiansen
Aarhus, Denmark
Wed 20 10:00
EW2.1
Education Workshop 2: How to get your research published
Endocrine Connections
Aarhus, Denmark
S Cinti
Wed 20 09:00
S10.1
Symposium 10: Lipodystrophy - The perils of being thin
Familial partial lipodystrophy: an introduction
A Clark
Wed 20 10:20
EW2.3
Education Workshop 2: How to get your research published
Journal of Endocrinology
Wed 20 10:25
EW2.4
Education Workshop 2: How to get your research published
Journal of Molecular Endocrinology
A Comninos
Mon 18 15:30
OC1.8
Oral Communications 1: Young Endocrinologists's Prize Session
Kisspeptin advances ovulation in healthy women
J Connell
Tue 19
MTE3
Meet the Expert 3
Investigation of patients with suspected mineralocorticoid hypertension
G Conway
Tue 19
MTE1
Meet the Expert 1
Turner Syndrome / pregnancy / cardiac risk
B Conway-Campbell
Tue 19 08:45
S6.2
Symposium 6: Making the glucocorticoid clock run smoothly
Molecular dynamics of ultradian glucocorticoid receptor action
P Coskeran
Wed 20 10:45
N1.5
Nurse Session 1: The Patient Pathway for Pituitary Care
Post-operative and follow-up care
J Denes
Tue 19 16:45
OC5.2
Oral Communications 5: Pituitary and neoplasia
The role of the microRNA miR-34a in the regulation of aryl hydrocarbon receptor interacting protein (AIP)
Tue 19 18:15
OC5.8
Oral Communications 5: Pituitary and neoplasia
Pituitary adenoma and phaeochromocytoma/paraganglioma - a novel syndrome with a heterogeneous genetic background
T Dickmeis
Karlsruhe, Germany
Tue 19 08:15
S6.1
Symposium 6: Making the glucocorticoid clock run smoothly
Monitoring glucocorticoid signalling and circadian clock function with transgenic zebrafish reporter lines
Karlsruhe, Germany
S Dickson
Gothenburg, Sweden
Wed 20 14:15
S11.2
Symposium 11: Guts, brains and bariatric surgery
Gut-brain communication - Ghrelin
Gothenburg, Sweden
M Donaldson
Tue 19 09:55
CMW2.6
Clinical Management Workshop 2: How Do I Do It?
How do I - and how should I - induce puberty in females?
A Drakesmith
Mon 18 11:30
S1.2
Symposium 1: Irn Bru, to drink or not to drink: endocrinology and iron
The iron regulatory hormone hepcidin
S Driesche
Tue 19 09:15
OC3.5
Oral Communications 3: Reproduction, growth and development
Effects of in utero exposure to acetaminophen (paracetamol) on steroidogenesis by the rat and human fetal testis
Professor Maralyn Druce
London, UK
Wed 20 15:05
N2.3
Nurse Session 2: Late Effects
Gonadal late effects
London, UK
C Dulac
Cambridge, USA
Mon 18 17:15
S5.3
Symposium 5: Sex in the brain
Neuronal circuits underlying sex specific social behaviour
Cambridge, USA
R Duncan
Wed 20
MTE8
Meet The Expert 8
Live Cell Imaging
R Eastell
Mon 18 13:45
S4.1
Symposium 4: New Bone Biology - Is there life after RANK ligand?
New bone biology and Cathepsin K inhibitors
P Esbrit
Madrid, Spain
Mon 18 14:45
S4.3
Symposium 4: New Bone Biology - Is there life after RANK ligand?
Parathyroid hormone related peptide as a potential treatment for osteoporosis
Madrid, Spain
H Escobar-Morreale
Madrid, Spain
Thu 21 12:00
CMW3.4
Clinical Management Workshop 3: PCOS - why, how and what
Diagnosis and Management of hirsuitism
Madrid, Spain
R Evans
La Jolla, USA
Mon 18 11:00
S1.1
Symposium 1: Irn Bru, to drink or not to drink: endocrinology and iron
Iron homeostasis: who are the major players?
La Jolla, USA
Tue 19
PL1
SfE Dale Medal Lecture
Nuclear receptors and AMPK: can exercise mimetics cure diabetes?
La Jolla, USA
P Foster
Tue 19 14:45
YE1.4
YE Symposium: Maintaining your endocrine career despite what life throws at you
Non-traditional career paths towards an acedemic career
R Fowkes
Mon 18 16:15
EW1.1
Education Workshop 1: Teaching and Learning in Endocrinology
Undergraduate research participation: going beyond 'students as producers'
J Franklyn
Tue 19 16:30
D1.1
Debate
FOR
W Fraser
Mon 18 16:45
CMW1.2
Clinical Management Workshop 1: Management controversies in parathyroid disease
Parathyroid hormone, vitamin D and chronic kidney disease
T Freeman
Mon 18 14:45
APW1.3
Applied Physiology Workshop
Analysis and visualisation of biological networks
C Gaston-Massuet
Mon 18 18:00
YEP1.2
Young Endocrinologists Prize Lectures
Pituitary development: the answer, is blowing in the Wnt
L Gathercole
Mon 18 14:30
OC1.4
Oral Communications 1: Young Endocrinologists's Prize Session
A Serum MicroRNA Profile Potentially Associated with Glucocorticoid Mediated Insulin Resistance
M Gershengorn
Bethesda, USA
Wed 20 09:30
S9.2
Symposium 9: Novel aspects of GPCR signalling
Novel aspects of TSH receptor signalling
Bethesda, USA
A Gogakos
Mon 18 17:00
OC2.4
Oral Communications 2: Steroids and thyroid
THRA or DIO2 mutations are not a common cause of high bone mass in humans
N Gordon
Wed 20 09:30
N1.2
Nurse Session 1: The Patient Pathway for Pituitary Care
Peri-operative care-surgical aspects
F Gribble
Wed 20 14:45
S11.3
Symposium 11: Guts, brains and bariatric surgery
Targeting gut hormone release to treat obesity
A Grossman
Tue 19
Ipsen satellite symposium
Stabilising tumour growth in patients with NETs
Wed 20
MTE 6
Meet the Expert 6
Malignant Phaeochromocytoma
Wed 20
Viropharma satellite symposium
Current challenges in the management of AI: goals of therapy
M Gurnell
Tue 19
Ipsen satellite symposium
Tumour response to presurgical lanreotide Autogel therapy in the ACROPAT trial
L Hand
Tue 19 10:00
OC3.8
Oral Communications 3: Reproduction, growth and development
Adiponectin induces GSK3 kinase-mediated cross-tolerance to endotoxin in macrophages
N Hanley
Tue 19 16:30
MTE4
Meet The Expert 4
Induced plurripotent stem cells as an endocrine tool
P Hannaert
Poitiers, France
Mon 18 15:15
APW1.4
Applied Physiology Workshop
Modelling the circulating renin-angiotensin system and its efefcts on blood pressure
Poitiers, France
R Hardy
Tue 19 09:45
OC3.7
Oral Communications 3: Reproduction, growth and development
Disruption of Mesenchymal Glucocorticoid Signaling Attenuates Embryonic Lung Development and Results in Post Natal Lethality in Mice
Z Hassan-Smith
Mon 18 14:15
OC1.3
Oral Communications 1: Young Endocrinologists's Prize Session
11β-HSD1KO mice are protected from glucocorticoid dependent age-associated muscle atrophy
R Holt
Wed 20 07:15
MTE7
Meet the Expert 7
Hormone misuse in sport and leisure
D Hosking
Mon 18 17:45
CMW1.4
Clinical Management Workshop 1: Management controversies in parathyroid disease
Medical management of parathyroid disease
S Howles
Mon 18 15:15
OC1.7
Oral Communications 1: Young Endocrinologists's Prize Session
Autosomal dominant hypocalcemia type 2 is caused by germline GNA11 gain-of-function mutations
T Howlett
Tue 19 14:30
YE1.3
YE Symposium: Maintaining your endocrine career despite what life throws at you
Getting useful research results from routine NHS activity
I Huhtaniemi
Wed 20 10:00
S9.3
Symposium 9: Novel aspects of GPCR signalling
In vivo dimerization of LH receptors
K Hussain
Thu 21 11:30
CMW4.3
Clinical Management Workshop 4: Managing Hypoglycaemia
Hypoglycaemia in neonates and children
L Ibanez
Barcelona, Spain
Thu 21 11:00
CMW3.2
Clinical Management Workshop 3: PCOS - why, how and what
Treatment of PCOS in Non-Obese Adolescents
Barcelona, Spain
S Jamal
Toronto, Canada
Mon 18 15:15
S4.4
Symposium 4: New Bone Biology - Is there life after RANK ligand?
Organic nitrates for the treatment of postmenopausal osteoporosis
Toronto, Canada
N James
Tue 19 08:15
CMW2.1
Clinical Management Workshop 2: How Do I Do It?
How do I manage testosterone replacement after prostate cancer therapy?
F Jean-Alphonse
Tue 19 08:15
OC3.1
Oral Communications 3: Reproduction, growth and development
Identification of very early sorting endosomes that spatially program gonadotrophin hormone receptor signalling
G Johannsson
Gothenburg, Sweden
Wed 20
Viropharma satellite symposium
How a dual-release preparation can help overcome challenges
Gothenburg, Sweden
Dr Kim Jonas
London, UK
Tue 19 08:45
OC3.3
Oral Communications 3: Reproduction, growth and development
Regulation of G protein-coupling specificity via cis and trans activation of the luteinising hormone/chorionic gonadotrophin receptor (LHCGR)
London, UK
U Kaiser
Boston, USA
Wed 20 09:00
S9.1
Symposium 9: Novel aspects of GPCR signalling
GPCR mutations and reproduction
Boston, USA
Dr Niki Karavitaki
Birmingham, UK
Tue 19 16:30
S8.1
Symposium 8: Non functioning pituitary tumours
Epidemiology and natural history of pituitary tumours
Birmingham, UK
E Keverne
Mon 18 16:45
S5.2
Symposium 5: Sex in the brain
Importance of genomic imprinting in the evolution and development of the maternal brain
C Koppen
Saarbrucken, Germany
Wed 20 10:30
S9.4
Symposium 9: Novel aspects of GPCR signalling
Allosteric LH receptor regulation
Saarbrucken, Germany
Márta Korbonits
Wed 20
PL6
SfE Medal Lecture
Genes and Giants
O Koulouri
Tue 19 17:15
OC5.4
Oral Communications 5: Pituitary and neoplasia
Clinical, metabolic, biochemical and radiological characterisation of patients with thyrotropinomas reveals a highly variable phenotype
F Labrie
Quebec, Canada
Tue 19
PL2
SfE Hoffenberg International Medal Lecture
Multiple applications of intracrinology in clinical medicine
Quebec, Canada
D Landau
Wed 20 10:15
N1.4
Nurse Session 1: The Patient Pathway for Pituitary Care
Radiotherapy and post operative management
S Larkin
Tue 19 17:30
OC5.5
Oral Communications 5: Pituitary and neoplasia
Densely and sparsely granulated somatotroph adenomas - clinical, genetic and histological differences
G Lavery
Tue 19 14:00
YE1.1
YE Symposium: Maintaining your endocrine career despite what life throws at you
Maintaining an active basic research career whilst juggling an academic and personal life
J Lazarus
Thu 21 10:30
SE1.1
Senior Endocrinologists' Session
The UK is an underdeveloped country - The Iodine Scandal
G Leese
Mon 18 17:15
CMW1.3
Clinical Management Workshop 1: Management controversies in parathyroid disease
'Mild hyperparathyroidism' - what determines clinical outcome?
R Legro
Hershey, USA
Thu 21 11:30
CMW3.3
Clinical Management Workshop 3: PCOS - why, how and what
Is there a place for Metformin in PCOS?
Hershey, USA
G Leng
Mon 18 13:45
APW1.1
Applied Physiology Workshop
Modelling neuroendocrine systems
M Levy
Mon 18 17:15
EW1.3
Education Workshop 1: Teaching and Learning in Endocrinology
Recommended standards for undergraduate medical education
S Lightman
Thu 21
PL7
Clincal Endocrinology Trust Lecture
The dynamics of hypothalamic-pituitary-adrenal activity
K Lines
Tue 19 16:30
OC5.1
Oral Communications 5: Pituitary and neoplasia
Genetic background influences tumour phenotype in heterozygous Men1 knockout mice
D Livingstone
Tue 19 15:15
OC4.6
Oral Communications 4: Obesity, metabolism and bone
Transgenic disruption of 5alpha-reductase1 increases susceptibility to liver fibrosis
L Lumey
Columbia, USA
Mon 18 12:00
S3.3
Symposium 3: Nurture not nature: epigenetics and disease susceptibility
Epigenetic differences associated with prenatal exposure to famine in humans
Columbia, USA
A Madathil
Mon 18 16:30
OC2.2
Oral Communications 2: Steroids and thyroid
Abnormal cardiac bio-energetics in subclinical hypothyroidism; cardiac magnetic resonance spectroscopic study
V Marks
Thu 21 12:35
SE1.6
Senior Endocrinologists' Session
Suspicious hypoglycaemia: was it insulin?
J McKenna
Dublin, Ireland
Thu 21 10:55
SE1.2
Senior Endocrinologists' Session
Robert Graves and his remarkable colleagues
Dublin, Ireland
M Meaney
Montreal, Canada
Wed 20
PL4
SfE Translatlantic Medal Lecture
Environmental regulation of neuroendocrine systems through epigenetic mechanisms
Montreal, Canada
S Morgan
Tue 19 14:15
OC4.2
Oral Communications 4: Obesity, metabolism and bone
11β-HSD1 Knockout Mice are Protected from the Adverse Metabolic Effects of Exogenous Glucocorticoid Excess
Dr Robert Murray
Leeds, UK
Wed 20 13:45
N2.1
Nurse Session 2: Late Effects
Pituitary late effects
Leeds, UK
D Nanus
Mon 18 13:45
OC1.1
Oral Communications 1: Young Endocrinologists's Prize Session
TNFα directly regulates in vivo corticosteroid metabolism in inflammatory arthritis
S Nef
Geneva, Switzerland
Mon 18 11:30
S2.2
Symposium 2: Hormones Maketh Man
The role of the Sertoli cell in driving 'maleness'
Geneva, Switzerland
A Nesbit
Tue 19 15:30
OC4.7
Oral Communications 4: Obesity, metabolism and bone
Familial Hypocalciuric Hypercalcaemia Type 3 (FHH3) is Caused by Mutations in Adaptor Protein 2 Sigma 1 (AP2S1)
Dr Paul Newey
Dundee, United Kingdom
Tue 19 14:15
YE1.2
YE Symposium: Maintaining your endocrine career despite what life throws at you
Juggling a clinical workload: and academic research
Dundee, United Kingdom
Tue 19 17:00
OC5.3
Oral Communications 5: Pituitary and neoplasia
Whole-exome sequencing studies of non-functioning pituitary adenomas
Dundee, United Kingdom
L Nieman
Bethesda, USA
Thu 21
PL8
Clinical Endocrinology Trust Visiting Professor Lecture
Evaluation of the adrenal cortex: Future possibilities
Bethesda, USA
E Nieschlag
Muenster, Germany
Thu 21 11:20
SE1.3
Senior Endocrinologists' Session
Should the Aging Male Become a Father?
Muenster, Germany
G Papacleovaulou
Tue 19 14:45
OC4.4
Oral Communications 4: Obesity, metabolism and bone
Cholestatic pregnancy programmes metabolic disease in the offspring
S Papapoulos
Leiden, The Netherlands
Mon 18 14:15
S4.2
Symposium 4: New Bone Biology - Is there life after RANK ligand?
Inhibition of sclerostin in the treatment of osteoporosis
Leiden, The Netherlands
S Pearce
Newcastle, UK
Tue 19 09:45
S6.4
Symposium 6: Making the glucocorticoid clock run smoothly
Retraining the HPA axis: how to cure adrenal insufficiency
Newcastle, UK
K Perry
Tue 19 15:00
YE1.5
YE Symposium: Maintaining your endocrine career despite what life throws at you
Re-establishing your research profile after a career break (academic perspective)
P Peterson
Wed 20 14:15
S12.2
Symposium 12: Thymic function and autoimmune endocrine disease
Anti-cytokine autoantibodies in AIRE deficient humans and mice
D Pfaff
New York, USA
Mon 18 17:45
S5.4
Symposium 5: Sex in the brain
Hormone-dependent chromatin modifications regulating sexually differentiated animal behaviour
New York, USA
P Prasad
Mon 18 17:15
OC2.5
Oral Communications 2: Steroids and thyroid
A mutation in thioredoxin reductase 2 (TXNRD2) is associated with a predominantly adrenal phenotype in humans
V Rakyan
Mon 18 11:00
S3.1
Symposium 3: Nurture not nature: epigenetics and disease susceptibility
Epigenome-wide association studies for common human diseases
R Rey
Buenos Aires, Argentina
Mon 18 11:00
S2.1
Symposium 2: Hormones Maketh Man
Anti-müllerian hormone - a Sertoli cell hormone that can be used as a predictor of male hypogonadism
Buenos Aires, Argentina
R Richardson
Tue 19 14:00
OC4.1
Oral Communications 4: Obesity, metabolism and bone
Glucocorticoid receptor deficiency in cardiomyocytes causes pathological cardiac remodelling in mice.
R Robertson
Tue 19 09:30
OC3.6
Oral Communications 3: Reproduction, growth and development
Follistatin-Like 3 (FSTL3), a transforming growth factor β (TGFβ) ligand inhibitor, is essential for placental development in mice.
M Rodie
Tue 19 09:00
OC3.4
Oral Communications 3: Reproduction, growth and development
Characterising changes in the in vivo male rodent brain using Magnetic Resonance Spectroscopy
M Rodriguez-Fernandez
Santa Barbara, USA
Mon 18 14:15
APW1.2
Applied Physiology Workshop
Distinguishing normal, depressive and PTSD cortisol dynamics in humans through mathematical modelling
Santa Barbara, USA
R Ross
Tue 19 09:15
S6.3
Symposium 6: Making the glucocorticoid clock run smoothly
Diurnal cortisol delivery: a novel tool for adrenal insufficiency
C Roux
Wed 20 13:45
S11.1
Symposium 11: Guts, brains and bariatric surgery
How does bariatric surgery cure obesity?
G Ryan
Mon 18 16:45
OC2.3
Oral Communications 2: Steroids and thyroid
A bi-transgenic murine model of PTTG and PBF overexpression in the thyroid gland
D Sansom
Wed 20 15:15
S12.4
Symposium 12: Thymic function and autoimmune endocrine disease
Regulatory T cells, CTLA-4 and autoimmune disease
P Saunders
Tue 19 15:15
YE1.6
YE Symposium: Maintaining your endocrine career despite what life throws at you
Putting your best foot forward - what the funders' are looking for
D Savage
Wed 20 09:30
S10.2
Symposium 10: Lipodystrophy - The perils of being thin
Novel genetic causes of partial lipdystrophy
N Schoenmakers
Mon 18 16:15
OC2.1
Oral Communications 2: Steroids and thyroid
Loss-of-Function Mutations in IGSF1 Cause a Novel, X-Linked Syndrome of Central Hypothyroidism and Testicular Enlargement
L Seal
Tue 19 08:55
CMW2.3
Clinical Management Workshop 2: How Do I Do It?
How do I monitor and follow up transgender patients using hormonal therapies?
P Selby
Mon 18 17:45
EW1.4
Education Workshop 1: Teaching and Learning in Endocrinology
Postgraduate training in endocrinolgoy and diabetes - developing the curriculum and assessments
Professor Robert Semple
Edinburgh, UK
Thu 21 12:00
CMW4.4
Clinical Management Workshop 4: Managing Hypoglycaemia
Autoimmune hypoglycaemia - when and how to look for anti-insulin and anti-insulin receptor antibodies
Edinburgh, UK
J Service
Rochester, USA
Thu 21 11:00
CMW4.2
Clinical Management Workshop 4: Managing Hypoglycaemia
Insulinoma - new developments in localisation and therapy
Rochester, USA
A Sinha
Mon 18 15:00
OC1.6
Oral Communications 1: Young Endocrinologists's Prize Session
Improving the Vitamin D status of Vitamin D deficient adults is associated with improved mitochondrial oxidative function in skeletal muscle
L Smith
Mon 18 12:00
S2.3
Symposium 2: Hormones Maketh Man
Androgens and male fertility - a long way from the black box theory
V Smith
Tue 19 17:45
OC5.6
Oral Communications 5: Pituitary and neoplasia
Manipulating PBF/PTTG1IP phosphorylation status to improve radioiodine uptake in thyroid and other tumours
A Spada
Milan, Italy on behalf of the author group
Wed 20
PL3
SfE European Medal Lecture
cAMP in the pituitary: An old messenger for multiple signals
Milan, Italy on behalf of the author group
A Stears
Wed 20 10:30
S10.4
Symposium 10: Lipodystrophy - The perils of being thin
Approach to lipodystrophy management - a new national service
P Stewart
Birmingham, UK
Wed 20
Viropharma satellite symposium
Current challenges in the management of AI: why current therapy fails our patients
Birmingham, UK
Y Takahama
Tokushima, Japan
Wed 20 14:45
S12.3
Symposium 12: Thymic function and autoimmune endocrine disease
Attacking the endocrine system: what is AIRE doing?
Tokushima, Japan
G Tan
Tue 19
MTE2
Meet the Expert 2
Diabetes metellitus, endocrinology and the impact of GP commissioning
N Thomas
Wed 20 09:45
N1.3
Nurse Session 1: The Patient Pathway for Pituitary Care
The Surgery
A Tiganescu
Mon 18 17:45
OC2.7
Oral Communications 2: Steroids and thyroid
11β-hydroxysteroid dehydrogenase type 1: A role in skin wound healing
R Upreti
Mon 18 14:45
OC1.5
Oral Communications 1: Young Endocrinologists's Prize Session
Inhibition of 5α-reductase type 1 with dutasteride impairs insulin sensitivity
F Villarroya
Barcelona, Spain
Wed 20 10:00
S10.3
Symposium 10: Lipodystrophy - The perils of being thin
HIV and lipodystrophy
Barcelona, Spain
G Walls
Mon 18 18:00
YEP1.1
Young Endocrinologists Prize Lectures
Clinical and pre-clinical studies of neuroendocrine tumours (NETs) in Multiple Endocrine Neoplasia type 1 (MEN1), and evaluation of MEN1 gene replacement therapy for MEN1-associated NETs.
Tue 19 18:00
OC5.7
Oral Communications 5: Pituitary and neoplasia
Uterine tumours with loss of progesterone receptor expression develop in mice deleted for a Cell Division Cycle 73 (CDC73) allele
J Wass
Thu 21 09:30
CG1.1
Clinical Guidelines
Consequences of cancer therapy
F Weber
Essen, Germany
Wed 20 10:10
EW2.2
Education Workshop 2: How to get your research published
Endocrine-Related Cancer
Essen, Germany
A Weetman
Tue 19 17:00
D1.2
Debate
AGAINST
Anne White
Manchester, UK
Mon 18 11:30
S3.2
Symposium 3: Nurture not nature: epigenetics and disease susceptibility
Nutritional programming of epigenetics in metabolic syndrome
Manchester, UK
M Wierman
Denver, USA
Tue 19 17:00
S8.2
Symposium 8: Non functioning pituitary tumours
Pathological mechanisms underlying non-functioning pituitary tumours
Denver, USA
T Wilkin
Thu 21 12:10
SE1.5
Senior Endocrinologists' Session
Type 1 and Type 2 Diabetes are the same disorder of insulin resistance, but with different genetic backgrounds
G Williams
Tue 19 14:00
S7.1
Symposium 7: Thyroid Hormone Receptors - mutations and implications
Physiologically distinct roles for thyroid hormone receptor isoforms
D Wood
Mon 18 16:45
EW1.2
Education Workshop 1: Teaching and Learning in Endocrinology
Clinical skills delivery
M Zatelli
Ferrara, Italy
Tue 19 17:30
S8.3
Symposium 8: Non functioning pituitary tumours
Pathological markers of aggressive pituitary tumour behaviour - use of MGMT?
Ferrara, Italy
Z Zhang
Mon 18 14:00
OC1.2
Oral Communications 1: Young Endocrinologists's Prize Session
Macrophage-specific 11β-hydroxysteroid dehydrogenase type 1 deficiency promotes angiogenesis but impairs resolution of K/BxN serum induced arthritis
H Zoller
Innsbruck, Austria
Mon 18 12:00
S1.3
Symposium 1: Irn Bru, to drink or not to drink: endocrinology and iron
'The Celtic disease' - haemochromatosis: a disease of iron overload
Innsbruck, Austria
P203
Evaluation of efficacy of transdermal delivery of chloroquine on Plasmodium berghei-infected male Sprague-Dawley rats and effects on  blood glucose and  renal electrolyte handling
Cephas T Murabayane
P206
ILEAL INTERPOSITION WITH DIVERTED SLEEVE GASTRECTOMY FOR TREATMENT OF TYPE 2 DIABETES
SUNIL KUMAR KOTA
P198
INFLAMMATORY MARKERS IN DIABETIC FOOT AND IMPACT OF VITAMIN D DEFICIENCY
SUNIL KUMAR KOTA
P207
Polycystic ovary syndrome has no independent effect on vascular, inflammatory or thrombotic markers when matched for obesity.
Hassan Kahal
P227
Short term calorie restriction : Effects on endocrine markers of nutritional status.
Swati Jain
P243
Re-occurrence of pancreatic insulinoma: an usual cause of hypoglycaemia
Charles Anwuzia-Iwegbu
P199
The Possible Involvement of the Receptor for Advanced Glycation End Products (RAGE) in Vascular Senescence in Diabetes
Nalinie Joharatnam
P236
Improvement in Testosterone post Bariatric surgery
Vani Shankaran
P228
The development of a structured education programme to improve cardiovascular risk in women with Polycystic Ovary Syndrome (SUCCESS Study)
Hamidreza Mani
P200
Effects of Syzygium aromaticum-derived oleanolic acid administration on postprandial glucose concentration and key intestinal carbohydrate hydrolyzing enzymes of streptozotocin-induced diabetic rats
Cephas T Musabayane
P241
Unusual case of Hypoglycaemia in diabetic patient
Aye Nyunt
P229
Hypogonadism in males with Type 2 Diabetes Mellitus
Adewole Adesanya
P183
The effects of Syzygium aromaticum-derived oleanolic acid on reactive oxygen species in the heart, liver and kidney of STZ-induced diabetic rats
Cephas T Musabayane
P208
Leptin in serum and vitreous humor, and retinal ob mRNA, in human diabetes.
Syed A Imran
P205
Irisin as a central regulator in energy homeostasis?
Milan K Piya
P230
Obesity-related hypogonadotrophic hypogonadism: recovery of normal pituitary-gonadal axis function following bariatric surgery
Anjali Santhakumar
P212
The Public distress domain of Quality of Life correlates directly and independently with BMI in pre-operative morbidly obese patients awaiting metabolic surgery
SYED ABDUS SABOOR AFTAB
P239
Preoperative characteristics of morbidly obese patients who achieved at least fifty percent excess weight loss post-metabolic Surgery
SYED ABDUS SABOOR AFTAB
P202
Vitamin D and insulin resistance: No association in healthy overweight people at high risk of cardiovascular disease.
Ian Wallace
P218
Weight loss after bariatric surgery in women of childbearing age
Aderinsola Alatishe
P213
Pregestational Body Mass Index Predicts Neonatal Hypoglycemia in Women with Gestational Diabetes
Ayesha Ahmad
P231
Risk Assessment of Adult Residents in Ile-Ife, South-Western Nigeria for Type 2 Diabetes Mellitus
Gbadebo Ajani
P184
Effects of Vitamin D supplementation on blood pressure, glucocorticoids and cardiovascular risk markers in healthy subjects
EMAD AL-DUJAILI
P219
Eating more quickly heightens overall systemic exposure to glucose and NEFA in the post-prandial phase, irrespective of energy expenditure in obese women
Thomas M Barber
P214
Effectiveness of bariatric surgery in women with and without polycystic ovarian syndrome
Angelos Kyriacou
P240
Glycaemic variability- does it make a difference in prediabetes?
Thomas Paul
P188
Human Abdominal Subcutaneous adipocytes as an active source of LpPLA2, influenced by fat depot and metabolic state, with LpPLA2 converting LDL into more potent atherogenic Ox-LDL, in vitro
Warunee Kumsaiyai
P232
Adrenal insufficiency post bariatric surgery
VANI SHANKARAN
P189
The role of glucocorticoid metabolism in bile acid homeostasis
Monica Naomi opiyo
P185
Knockdown of brain 11β-HSD1 does not lower body weight or improve insulin sensitivity
Erika Harno
P225
Non-Alcoholic Fatty Liver Disease in Patients Attending the National Severe Insulin Resistance Service.
Sarah M Leiter
P215
Octreotide therapy of chronic urticaria and angioedema after gastric bypass procedure
Jeanny Varghese
P220
Hepatic 11 ß-Hydroxysteroid Dehydrogenase Type 1 (11 ß-HSD1) is elevated following weight loss secondary to bariatric surgery.
Conor Woods
P237
Prevalence and Associated Risks for Metabolic Syndrome in Nigerians with Type 2 Diabetes Mellitus
David Soyoye
P209
The endocrine and metabolic characteristics of a large Bardet-Biedl syndrome clinic population
Safa Mujahid
P233
Pregnancy Outcome in a patient with Lipodystrophy and Type 2 Diabetes
Tolulope Shonibare
P180
A component of transcriptional PRC2 complex, enhancer of zest homology (EZH2), modulates endothelial cell responses to hypoxia and post-ischemic angiogenesis in a mouse model of limb ischemia
Tijana Mitic
P177
Association of calcium-sensing receptor polymorphisms with vascular calcification and glucose homeostasis in renal transplant recipients
Valerie N. Babinsky
P221
Brown adipose tissue identification in an adult human using IDEAL MRI
Narendra Reddy
P242
withdrawing insulin in a young person
mithun bhartia
P211